Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tiragolumab
Pharma
Roche, Daiichi-Seagen, LegoChem—Fierce Pharma Asia
Roche posts a positive TIGIT phase 3 result in Asia. Daiichi chalks up a win in its patent fight with Seagen. LegoChem sold a 25% stake to Orion.
Angus Liu
Jan 19, 2024 8:48am
Roche pharma CEO Anderson leaves in another leadership shuffle
Dec 12, 2022 9:52am
'The Top Line': The TIGIT aftermath, Q1 revenue growth and more
May 20, 2022 9:00am
Novartis, BMS, Innovent, Lilly, Akebia await FDA decisions
Mar 2, 2022 10:10am
